BioDelivery Sciences Appoints New Vice President of Manufacturing and Supply Chain

BioDelivery Sciences International has appointed Joseph (Jody) M. Lockhart as Vice President of Manufacturing and Supply Chain.  In this role, Mr. Lockhart will be responsible for overseeing all manufacturing-related activities for both BDSI's currently approved products, including the currently marketed product BUNAVAIL^®(buprenorphine and naloxone) buccal film as well as ONSOLIS (fentanyl buccal soluble film), which was reacquired from Meda Pharmaceuticals earlier this year.  Mr. Lockhart will also be responsible for scale up and manufacturing activities for BDSI's development pipeline.  Mr. Lockhart will report to Dr. Mark A. Sirgo, President and Chief Executive Officer. 

Mr. Lockhart joins BDSI with nearly 30 years of pharmaceutical development and manufacturing experience.  Most recently, Mr. Lockhart held the position of Vice President, Pharmaceutical Development and Manufacturing for Salix Pharmaceuticals where he established the pharmaceutical development and manufacturing team and contributed to the submission of 11 NDA's and FDA approvals, 16 product acquisitions, and the commercialization of 20 products.   

"As we continue to evolve as a fully integrated specialty pharmaceutical company, our ability to manage and control our manufacturing and supply chain has become critical," said Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI.  "Jody brings to BDSI a wealth of experience in this area, including the past 14 years overseeing this function for Salix.  We look forward to the leadership and significant expertise that Jody brings to BDSI as we continue to grow as an organization."